Log In
Print
BCIQ
Print
Print this Print this
 

CAT-1004

  Manage Alerts
Collapse Summary General Information
Company Catabasis Pharmaceuticals Inc.
DescriptionConjugate of salicylate and docosahexaenoic acid (DHA)
Molecular Target NF-kappa B (NF-kB)
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today